Federal Supply Schedule 36F79720D0175
Award Date
8/1/20
Last Date to Order
12/31/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Nexus Pharmaceuticals, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule (FSS) contract award 36F79724D0047 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,188,000.00 and a period of performance through December 31, 2028. The contract was awarded to Nnodum Pharmaceuticals Corp, a minority-owned and SBA-certified 8(a) small disadvantaged business. The contract is for the procurement of 65 I B, DRUGS,...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award contract,...
The Federal Supply Schedule contract award referenced is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSS Contract 65 I B) by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 12. The prime contractor is Haleon US LP, a for-profit manufacturer of goods. The contract has a total ceiling value of $9,867,650.00 and a period of performance extending through September 30, 2026. This is a multiple award schedule contract, meaning it...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Metuchen Pharmaceuticals LLC. The contract is for Pharmaceuticals and Drugs (FSS-61-IB) and has a ceiling value of $6,800,000 with a period of performance through February 14, 2025. The contract aims to procure a variety of pharmaceutical and hematology-related products for the VA's Veterans Integrated Service Network 12. As an FSS contract, it allows for the VA and other federal agencies to...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs to Exela Pharma Sciences LLC, provides a mechanism for the VA's Veterans Integrated Service Network 12 to efficiently procure a wide range of drugs, pharmaceuticals, and hematology-related products. The multiple-award contract has a ceiling value of $20,304,570.00 and a period of performance from September 29, 2024, to September 28, 2029. Exela Pharma Sciences, a minority-owned, self-certified small...